FDA Authorizes Updated COVID Boosters to Target Newest Variants
Aug. 31, 2022 – The FDA on Wednesday granted emergency use authorization to Omicron-specific COVID-19 vaccines made by Pfizer/BioNTech and Moderna. The agency cited data to support the safety and efficacy of this next generation of mRNA vaccines targeted toward variants of concern. If you’ve been waiting to get a variant-specific booster shot, you may … Read more